Mäkelä T P, Parvin J D, Kim J, Huber L J, Sharp P A, Weinberg R A
Whitehead Institute for Biomedical Research, Massachusetts Institute for Technology, Cambridge 02142, USA.
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5174-8. doi: 10.1073/pnas.92.11.5174.
Phosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II has been suggested to be critical for transcription initiation, activation, or elongation. A kinase activity specific for CTD is a component of the general transcription factor TFIIH. Recently, a cyclin-dependent kinase-activator kinase (MO15 and cyclin H) was found to be associated with TFIIH preparations and was suggested to be the CTD kinase. TFIIH preparations containing mutant, kinase-deficient MO15 lack CTD kinase activity, indicating that MO15 is critical for polymerase phosphorylation. Nonetheless, these mutant TFIIH preparations were fully functional (in vitro) in both basal and activated transcription. These results indicate that CTD phosphorylation is not required for transcription with a highly purified system.
RNA聚合酶II大亚基的羧基末端结构域(CTD)的磷酸化被认为对转录起始、激活或延伸至关重要。CTD特异性的激酶活性是通用转录因子TFIIH的一个组成部分。最近,发现一种细胞周期蛋白依赖性激酶激活激酶(MO15和细胞周期蛋白H)与TFIIH制剂相关联,并被认为是CTD激酶。含有突变的、激酶缺陷型MO15的TFIIH制剂缺乏CTD激酶活性,表明MO15对聚合酶磷酸化至关重要。尽管如此,这些突变的TFIIH制剂在基础转录和激活转录中(体外)均具有完全功能。这些结果表明,在高度纯化的系统中转录不需要CTD磷酸化。